Donald Trump Gilead Sciences Russia city Moscow hospital covid-19 president patient Donald Trump Gilead Sciences Russia city Moscow

Russian firm seeks to produce COVID-19 drug remdesivir without patent

Reading now: 591
www.livemint.com

Moscow: Russian drugmaker Pharmasyntez has asked the Kremlin to allow it to produce a generic version of U.S.

COVID-19 drug remdesivir, used to treat U.S. President Donald Trump, despite lacking a patent to do so, the firm's director said on Monday.Remdesivir is not available in Russia, Pharmasyntez's director Vikram Punia said, but a generic version cannot be produced and distributed without the consent of the patent-holder, U.S.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA